Sign inGet started

FEKETE MICHAEL

Insider CIK 1581383 · SGNT Director · SPNE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SPNE SeaSpine Holdings Corp D To issuer deriv2023-01-052023-01-095,015— $00SEC↗
SPNE SeaSpine Holdings Corp D To issuer deriv2023-01-052023-01-0918,096— $00SEC↗
SPNE SeaSpine Holdings Corp D To issuer deriv2023-01-052023-01-0959,910— $00SEC↗
SPNE SeaSpine Holdings Corp D To issuer2023-01-052023-01-09111,966— $00SEC↗
SPNE SeaSpine Holdings Corp A Award2022-06-012022-06-037,653— $0111,966SEC↗
SPNE SeaSpine Holdings Corp A Award2022-06-012022-06-0315,943— $0104,313SEC↗
SPNE SeaSpine Holdings Corp P Buy2021-08-202021-09-0210,000$14.80 $148.0K88,370SEC↗
SPNE SeaSpine Holdings Corp A Award2021-06-022021-06-043,001— $078,370SEC↗
SPNE SeaSpine Holdings Corp A Award2021-06-022021-06-046,253— $075,369SEC↗
SPNE SeaSpine Holdings Corp A Award2020-06-032020-06-055,518— $069,116SEC↗
SPNE SeaSpine Holdings Corp A Award2020-06-032020-06-058,488— $063,598SEC↗
SPNE SeaSpine Holdings Corp A Award2019-05-292019-05-317,262— $055,110SEC↗
SPNE SeaSpine Holdings Corp A Award2018-05-302018-05-318,857— $042,091SEC↗
SPNE SeaSpine Holdings Corp A Award2018-05-302018-05-315,757— $047,848SEC↗
SPNE SeaSpine Holdings Corp P Buy2017-11-102017-11-13930$10.25 $9.5K33,234SEC↗
SPNE SeaSpine Holdings Corp P Buy2017-11-082017-11-13560$10.25 $5.7K32,304SEC↗
SPNE SeaSpine Holdings Corp A Award2017-06-142017-06-1516,634— $031,744SEC↗
SPNE SeaSpine Holdings Corp P Buy2017-03-152017-03-165,100$6.65 $33.9K15,110SEC↗
SGNT Sagent Pharmaceuticals, In D To issuer deriv2016-08-292016-08-311,860$21.75 $40.5K0SEC↗
SGNT Sagent Pharmaceuticals, In D To issuer deriv2016-08-292016-08-311,381$21.75 $30.0K0SEC↗
SGNT Sagent Pharmaceuticals, In D To issuer deriv2016-08-292016-08-31691$21.75 $15.0K0SEC↗
SGNT Sagent Pharmaceuticals, In D To issuer deriv2016-08-292016-08-31592$21.75 $12.9K0SEC↗
SGNT Sagent Pharmaceuticals, In D To issuer deriv2016-08-292016-08-318,556$21.75 $186.1K0SEC↗
SGNT Sagent Pharmaceuticals, In U Tender2016-08-292016-08-312,041$21.75 $44.4K0SEC↗
SGNT Sagent Pharmaceuticals, In D To issuer2016-08-292016-08-312,283$21.75 $49.7K2,041SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise deriv2016-07-102016-07-13591— $0592SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise2016-07-102016-07-13591— $05,651SEC↗
SPNE SeaSpine Holdings Corp A Award deriv2016-06-072016-06-0918,096— $018,096SEC↗
SPNE SeaSpine Holdings Corp A Award2016-06-072016-06-0910,010— $010,010SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise deriv2016-02-252016-02-25230— $0691SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise deriv2016-02-252016-02-25460— $01,381SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise2016-02-252016-02-25230— $05,060SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise2016-02-252016-02-25460— $04,830SEC↗
SGNT Sagent Pharmaceuticals, In A Award deriv2016-02-222016-02-238,556— $08,556SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise deriv2016-02-222016-02-23567— $00SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise2016-02-222016-02-23567— $04,370SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise deriv2016-02-212016-02-23760— $0760SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise2016-02-212016-02-23760— $03,803SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise deriv2016-02-182016-02-22930— $01,860SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise2016-02-182016-02-22930— $03,043SEC↗
SPNE SeaSpine Holdings Corp A Award deriv2016-01-012016-01-055,015— $05,015SEC↗
SPNE SeaSpine Holdings Corp A Award deriv2015-08-012015-08-0460,811— $060,811SEC↗
SPNE SeaSpine Holdings Corp A Award deriv2015-08-012015-08-2059,910— $059,910SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise deriv2015-07-102015-07-14592— $01,183SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise2015-07-102015-07-14592— $02,113SEC↗
SGNT Sagent Pharmaceuticals, In A Award deriv2015-04-092015-04-13921— $0921SEC↗
SGNT Sagent Pharmaceuticals, In A Award deriv2015-02-252015-02-271,841— $01,841SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise deriv2015-02-182015-02-20930— $02,790SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise2015-02-182015-02-20930— $01,521SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise deriv2014-07-102014-08-07591— $01,775SEC↗
SGNT Sagent Pharmaceuticals, In M Exercise2014-07-102014-08-07591— $0591SEC↗
SGNT Sagent Pharmaceuticals, In A Award deriv2014-02-182014-02-193,720— $03,720SEC↗
SGNT Sagent Pharmaceuticals, In A Award deriv2013-07-102013-07-152,366— $02,366SEC↗